# Drug-Eluting Balloon or Drug-Eluting Stent in Acute Myocardial Infarction: A Randomized Controlled Trial

Study · id `cardio:ct-nct06746233` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06746233](<https://clinicaltrials.gov/study/NCT06746233>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06746233

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 598 participants.

## Technical summary

Registry record NCT06746233. Randomized; no masking; primary purpose treatment. Start 2024-12-25 (actual); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 598 participants (planned count; ClinicalTrials.gov record NCT06746233, source copy `cardio:ctgov-nct06746233-2026-03-30`, retrieved 2026-10-26)
- Started: 2024-12-25 (actual) (ClinicalTrials.gov record NCT06746233, source copy `cardio:ctgov-nct06746233-2026-03-30`, retrieved 2026-10-26)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06746233, source copy `cardio:ctgov-nct06746233-2026-03-30`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06746233, source copy `cardio:ctgov-nct06746233-2026-03-30`, retrieved 2026-10-26)
- Countries: Bosnia & Herzegovina; Serbia (ClinicalTrials.gov record NCT06746233, source copy `cardio:ctgov-nct06746233-2026-03-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06746233-2026-03-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Drug-Eluting Balloon or Drug-Eluting Stent in Acute Myocardial Infarction: A Randomized Controlled Trial
- Acronym: BOOST-AMI
- Condition: ST Elevation Myocardial Infarction (STEMI)
- Intervention (Device): Drug (paclitaxel) coated balloon (DCB)
- Intervention (Device): Second-generation Drug Eluting Stent (DES)
- Lead sponsor: Institute of Cardiovascular Diseases, Vojvodina
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Institute of Cardiovascular Diseases, Vojvodina (`cardio:org-institute-of-cardiovascular-diseases-vojvodina`)

## Provenance

Content hash: 85a6d7aef85ece518717a1aef17c34e3ea603dfb8fa6081c53d30bc32d0ae69e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
